Arcadia Science

Arcadia Science

Biotech R&D firm studying emerging organisms

Overview

Arcadia Science is a biotechnology R&D company that studies emerging research organisms to develop new scientific tools, methods, and applications. It works with academic institutions, pharmaceutical companies, and biotech firms to accelerate discoveries and translate them into practical outcomes. Its products and services come from research collaborations, licensing of proprietary tools, and development of new therapies or drug discovery programs. The company pursues open science by sharing findings to increase impact and usefulness. Overall, Arcadia aims to advance science across medicine, agriculture, and environmental science by turning insights from lesser-known organisms into commercially viable tools and solutions.

About Arcadia Science

Simplify's Rating
Why Arcadia Science is rated
C-
Rated C on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Biotechnology

Healthcare

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Profit-sharing aligns Arcadians with full research lifecycle success.
  • Open science boosts visibility and accelerates evolutionary biology adoption.
  • Machine learning publications expand protein engineering beyond traditional organisms.

What critics are saying

  • Revenue under $5M exhausts funding in 6-12 months.
  • Ginkgo Bioworks commoditizes tools via automated foundries in 12-24 months.
  • Open policy lets pharma replicate discoveries, eroding IP in 18-36 months.

What makes Arcadia Science unique

  • Arcadia leverages evolutionary biology for novel model organism development.
  • Arcadia incubates for-profit startups from its research platform.
  • Arcadia releases open tools like apps and pipelines for phylogenomics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Wellness Program

Company Equity

Company News

Silicon Valley Daily
Dec 14th, 2021
KlearNow received financing of $50M in Series B funding on Dec 13th 21'.

KlearNow, a provider of smart Logistics as a Service (LaaS), has raised $50 million in new capital to transform broken supply chains—simplifying and providing real-time cargo visibility to the customs clearance and drayage processes.

Recently Posted Jobs

Sign up to get curated job recommendations

Arcadia Science is Hiring for 8 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →